When Angelina Jolie revealed that she had undergone a double mastectomy in 2013 because she tested positive for the rare hereditary BRCA1 gene—which, along with BRCA2, increases a woman's chances of developing breast and ovarian cancer—many women probably began wondering about their own susceptibility to the gene mutation.
Update: In March 2015, Jolie announced that she had surgery to remove her ovaries and fallopian tubes because she had received new information that her risk for ovarian cancer could increase.
As a public service, ECRI Institute has updated its evidence-based reports and special consumer guide. These resources are free, and are intended to increase understanding of the BRCA gene mutation and the implications for testing and treatment.
Please click the relevant button to download the reports and access other links.
Healthcare Professionals Consumers